Cargando…

Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation

Osteoclasts, bone-specialized multinucleated cells, are responsible for bone destructive diseases such as rheumatoid arthritis and osteoporosis. Natural plant-derived products have received substantial attention given their potential therapeutic and preventive activities against bone destructive dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Xiangying, Wu, Wenbin, Yang, Yue, Wan, Hongye, Li, Xiaomin, Zhong, Michun, Zhao, Hongyan, Su, Xiaohui, Jia, Shiwei, Ju, Dahong, Lin, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372222/ https://www.ncbi.nlm.nih.gov/pubmed/25889035 http://dx.doi.org/10.1186/s12967-015-0440-1

Ejemplares similares

Correction to: Total saponin from Anemone flaccida Fr. Schmidt abrogates osteoclast differentiation and bone resorption via the inhibition of RANKL-induced NF-κB, JNK and p38 MAPKs activation
por: Kong, Xiangying, et al.
Publicado: (2021)

Triterpenoid Saponin W3 from Anemone flaccida Suppresses Osteoclast Differentiation through Inhibiting Activation of MAPKs and NF-κB Pathways
por: Kong, Xiangying, et al.
Publicado: (2015)

Alcohol extracts from Anemone flaccida Fr. Schmidt treat rheumatoid arthritis via inhibition of synovial hyperplasia and angiogenesis
por: Rao, Qi, et al.
Publicado: (2023)

Appropriate Reference Genes for RT-qPCR Normalization in Various Organs of Anemone flaccida Fr. Schmidt at Different Growing Stages
por: Zhao, Zeying, et al.
Publicado: (2021)

The Antitumor Effects of Triterpenoid Saponins from the Anemone flaccida and the Underlying Mechanism
por: Han, Lin-Tao, et al.
Publicado: (2013)

Comprehensive Analysis of the Triterpenoid Saponins Biosynthetic Pathway in Anemone flaccida by Transcriptome and Proteome Profiling
por: Zhan, Chuansong, et al.
Publicado: (2016)

The complete chloroplast genome of a medicinal plant Anemone flaccida (Ranunculaceae)
por: Tang, Yuwen, et al.
Publicado: (2020)

Crude triterpenoid saponins from Anemone flaccida (Di Wu) exert anti-arthritic effects on type II collagen-induced arthritis in rats
por: Liu, Qing, et al.
Publicado: (2015)

Bisphosphonate‐enoxacin inhibit osteoclast formation and function by abrogating RANKL‐induced JNK signalling pathways during osteoporosis treatment
por: Xu, Qiang, et al.
Publicado: (2021)

Vav1 inhibits RANKL-induced osteoclast differentiation and bone resorption
por: Jang, Jin Sun, et al.
Publicado: (2019)

Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption
por: McDonald, Michelle M., et al.
Publicado: (2021)

Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption
por: McDonald, Michelle M., et al.
Publicado: (2021)

ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
por: Liang, Xinyue, et al.
Publicado: (2021)

Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway
por: Han, Lin-tao, et al.
Publicado: (2016)

Triterpenoid Saponins from Anemone flaccida Suppress Tumor Cell Proliferation by Regulating MAPK, PD1/PDL1, and STAT3 Signaling Pathways and Altering Cancer Metabolism
por: Han, Lintao, et al.
Publicado: (2019)

Structure identification, antitumor activity and mechanisms of a novel polysaccharide from Ramaria flaccida (Fr.) Quél
por: Dong, Mingming, et al.
Publicado: (2020)

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
por: Lim, Soomin, et al.
Publicado: (2023)

DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling
por: Kaifu, Tomonori, et al.
Publicado: (2023)

M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts
por: Hodge, Jason M., et al.
Publicado: (2011)

RO4929097 regulates RANKL-induced osteoclast formation and LPS-mediated bone resorption
por: Huang, Tao, et al.
Publicado: (2021)

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity
por: He, Jianbo, et al.
Publicado: (2021)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
por: Hong, Guoju, et al.
Publicado: (2017)

Water extract of Uncaria sinensis suppresses RANKL-induced bone loss by attenuating osteoclast differentiation and bone resorption
por: Ha, Hyunil, et al.
Publicado: (2017)

ADR3, a next generation i-body to human RANKL, inhibits osteoclast formation and bone resorption
por: Qiu, Heng, et al.
Publicado: (2023)

Muramyl Dipeptide Enhances Lipopolysaccharide-Induced Osteoclast Formation and Bone Resorption through Increased RANKL Expression in Stromal Cells
por: Ishida, Masahiko, et al.
Publicado: (2015)

Hesperetin Prevents Bone Resorption by Inhibiting RANKL-Induced Osteoclastogenesis and Jnk Mediated Irf-3/c-Jun Activation
por: Zhang, Qiang, et al.
Publicado: (2018)

Fangchinoline protects against bone loss in OVX mice via inhibiting osteoclast formation, bone resorption and RANKL-induced signaling
por: Zhou, Lin, et al.
Publicado: (2020)

Osteoclasts secrete osteopontin into resorption lacunae during bone resorption
por: Luukkonen, Jani, et al.
Publicado: (2019)

ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3
por: Zhang, Yufeng, et al.
Publicado: (2021)

Microcracks and Osteoclast Resorption Activity In Vitro
por: Rumpler, Monika, et al.
Publicado: (2012)

RANKL-Induced Btn2a2 – A T Cell Immunomodulatory Molecule – During Osteoclast Differentiation Fine-Tunes Bone Resorption
por: Frech, Michael, et al.
Publicado: (2021)

Quality Control of Glehniae Radix, the Root of Glehnia Littoralis Fr. Schmidt ex Miq., Along its Value Chains
por: Chen, Yuan, et al.
Publicado: (2021)

Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL-mediated NF-κB and JNK and their downstream signalling pathways
por: Huang, Xiao-Lin, et al.
Publicado: (2022)

The effects of seeding density and osteoclastic supplement concentration on osteoclastic differentiation and resorption
por: Remmers, Stefan J.A., et al.
Publicado: (2022)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
por: Yan, Liuliu, et al.
Publicado: (2019)

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
por: Kim, Ha-Neui, et al.
Publicado: (2012)

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro
por: Wang, Chuandong, et al.
Publicado: (2017)

GPR120 Inhibits RANKL-Induced Osteoclast Formation and Resorption by Attenuating Reactive Oxygen Species Production in RAW264.7 Murine Macrophages
por: Sithole, Cynthia, et al.
Publicado: (2021)

The Schmidt syndrome
por: Siniscalchi, Carmine, et al.
Publicado: (2017)

Effects of light irradiation on essential oil biosynthesis in the medicinal plant Asarum heterotropoides Fr. Schmidt var. mandshuricum (Maxim) Kitag
por: Wang, Zhiqing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1r9hhfhhef32bsbi7c42115cbr